Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

Go back to Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
(NASDAQ: TRAW) Delayed: 0.77 -0.04 (4.94%)
Previous Close $0.81    52 Week High
Open $0.82    52 Week Low
Day High $0.85    P/E N/A 
Day Low $0.76    EPS
Volume 238,592